Merit Medical SystemsFRA:MM3 +1.74%86 Net Margin % is 10.74% as of Mar. 2026, which is 131% above its 10-year median of 4.64. GuruFocus rates FRA:MM3 with a GF Score™ of 86/100 and a GF Value™ of €81.73 (Modestly Undervalued). Among 817 Medical Devices & Instruments companies, Merit Medical Systems ranks better than 70.5% on this metric.
The historical rank and industry rank for Merit Medical Systems's Net Margin % or its related term are showing as below:
FRA:MM3'
s Net Margin % Range Over the Past 10 Years
Min: -1.02 Med: 4.64 Max: 9.03
Current: 9.03
FRA:MM3's Net Margin % is ranked better than 70.5% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs FRA:MM3: 9.03
Merit Medical Systems (FRA:MM3) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Merit Medical Systems Net Margin % Related Terms
Merit Medical Systems Net Margin % Historical Data
* Premium members only.
The historical data trend for Merit Medical Systems's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MM3 vs NVST, MMED, ICUI: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Merit Medical Systems's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merit Medical Systems Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's Net Margin % distribution charts can be found below:
* The bar in red indicates where Merit Medical Systems's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merit Medical Systems (FRA:MM3) has a Net Margin % of 10.74% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Merit Medical Systems and its competitors. This is 131% above median its historical median of 4.64. According to the industry distribution chart, Merit Medical Systems ranks #241 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 29.5%.
Is Merit Medical Systems' Net Margin % too high?
Merit Medical Systems' current Net Margin % of 10.74% is 131% above median its 10-year median of 4.64. The Medical Devices & Instruments industry median Net Margin % is 2.07. Merit Medical Systems' value of 10.74% is 418.8% above this industry median. Based on the distribution chart, Merit Medical Systems ranks #241 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Merit Medical Systems has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Merit Medical Systems' Net Margin % compare to NVST and MMED?
According to the Medical Devices & Instruments industry distribution chart, Merit Medical Systems ranks #241 out of 817 companies for Net Margin %. This puts Merit Medical Systems in the upper half of its industry. The industry median Net Margin % is 2.07. Merit Medical Systems' value of 10.74% is 418.8% above this benchmark. While the company's 10-year median is 4.64 vs. the industry median of 2.07, Merit Medical Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Merit Medical Systems's current Net Margin % of 10.74% is 418.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Merit Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Merit Medical Systems's current Net Margin % is 10.74%, which is 131% above median its own 10-year median of 4.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merit Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Merit Medical Systems (FRA:MM3) is currently considered Modestly Undervalued. The stock's GF Value™ is €81.73, compared to a current price of €58.50 — trading 28.4% below its estimated fair value. The current Net Margin % is 10.74%, which is 131% above median its 10-year median of 4.64 and 418.8% above the Medical Devices & Instruments industry median of 2.07. Merit Medical Systems' overall GF Score™ is 86/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Merit Medical Systems (FRA:MM3), the current Net Margin % is 10.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merit Medical Systems (FRA:MM3) Overvalued in 2026?
Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued.
The current stock price of €58.50 is trading 28.4% below its estimated GF Value™ of €81.73.
GuruFocus considers Merit Medical Systems to be Modestly Undervalued.
Key valuation signals for FRA:MM3:
Net Margin %: 10.74% (131% above median its 10-year median of 4.64)
GF Value™: €81.73 vs. price of €58.50 (28.4% below fair value)
Industry Position: 418.8% above the Medical Devices & Instruments median (#241 of 817)
No single metric tells the full story. See the FRA:MM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
86GF Score
Get the complete analysis for FRA:MM3
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MM3 has been successfully added to your 
